ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1596

A Cell and Transcriptomic Atlas of the Infrapatellar Fat Pad from Patients with Knee Osteoarthritis: Identification of an Obesity-Associated Transcriptomic Signature

Hayley Peters1, Pratibha Potla1, Jason Rockel1, Keemo Delos Santos1, Shabana Vohra1, starlee lively2, Kim Perry3, Anthony Perruccio1, Nizar Mahomed4, Raja Rampersaud1, Rajiv Gandhi5 and Mohit Kapoor6, 1Schroeder Arthritis Institute, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 4Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and Division of Orthopaedics, Department of Surgery, University of Toronto, Toronto, ON, Canada, 6Schroeder Arthritis Institute, University Health Network and Department of Surgery, University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2023

Keywords: Fibroblasts, Other, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: Abstracts: Osteoarthritis & Joint Biology – Basic Science

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Knee osteoarthritis (KOA) is the most common form of arthritis that affects multiple knee joint tissues. The infrapatellar fat pad is the largest fat pad in the knee; however, its cell composition, including associated transcriptomic profiles, during KOA are not well described. Defining these cellular and transcriptomic profiles is crucial to defining the role of the infrapatellar fat pad in KOA pathogenesis. In this study, we subjected infrapatellar fat pad from KOA patients to high throughput single nuclei RNA sequencing (snRNAseq) and advanced bioinformatics to identify and define the cellular and transcriptomic atlas of KOA fat pad. Furthermore, we investigated transcriptomic differences in cell subsets identified in the fat pad of obese BMI patients compared to normal BMI patients with KOA.

Methods: Infrapatellar fat pad was obtained from late-stage KOA patients [KL grades III/IV; n=15; 53% females, 47% obese, BMI 30-40 and 53% non-obese, BMI 18.5-25] undergoing total knee arthroplasty and subjected to snRNAseq. Nuclei were sequenced on an Illumina NextSeq 550 using the 150bp high output sequencing kit. Cluster analysis, advanced bioinformatics and pathway analyses were employed to identify key cell types, cell subsets, cell transcriptomic profiles and biological pathways.

Results: Clustering analysis of snRNAseq data identified multiple cell populations based on canonical cell surface markers (Fig 1). The major cell types observed within the fat pad include fibroblasts (43.3%), macrophages (20.8%), adipocytes (18.5%), and endothelial cells (11.6%) (Fig 1). Interestingly, each major cell population identified had multiple cell subsets with unique transcriptomic profiles. Specifically, we identified nine distinct fibroblast cell subsets, four macrophage subsets, two adipocyte subsets and six endothelial subsets, each with unique transcriptomic profiles of highly expressed genes (Fig 2). We did not identify any differences in the proportions of fibroblast subsets when comparing normal BMI and obese BMI fat pads; however, we did identify a distinct transcriptomic signature with uniquely upregulated and downregulated genes in fibroblasts of the fat pad from obese BMI KOA patients compared to normal BMI KOA patients (Fig 3). We are now employing computational analyses of identified transcriptomic signatures and functional assays using primary fat pad fibroblasts of KOA patients to elucidate the mechanisms associated with the transcriptomic differences in obese BMI versus normal BMI KOA patients.

Conclusion: Using snRNAseq, we have generated a KOA fat pad transcriptomic and cell atlas. We have identified distinct cell subsets and transcriptomic profiles of fibroblasts, adipocytes, macrophages, and endothelial cells in the fat pad of patients with KOA. We also uncovered differences in transcriptomic profiles within fat pad fibroblasts of obese BMI KOA patients compared to normal BMI KOA patients. Further investigations regarding the contributions of these transcriptomic profiles and their function within the OA fat pad are currently underway.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: H. Peters: None; P. Potla: None; J. Rockel: None; K. Delos Santos: None; S. Vohra: None; s. lively: None; K. Perry: None; A. Perruccio: None; N. Mahomed: AIC, 4, ARTHUR HEALTH CORP, 3; R. Rampersaud: None; R. Gandhi: None; M. Kapoor: None.

To cite this abstract in AMA style:

Peters H, Potla P, Rockel J, Delos Santos K, Vohra S, lively s, Perry K, Perruccio A, Mahomed N, Rampersaud R, Gandhi R, Kapoor M. A Cell and Transcriptomic Atlas of the Infrapatellar Fat Pad from Patients with Knee Osteoarthritis: Identification of an Obesity-Associated Transcriptomic Signature [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/a-cell-and-transcriptomic-atlas-of-the-infrapatellar-fat-pad-from-patients-with-knee-osteoarthritis-identification-of-an-obesity-associated-transcriptomic-signature/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-cell-and-transcriptomic-atlas-of-the-infrapatellar-fat-pad-from-patients-with-knee-osteoarthritis-identification-of-an-obesity-associated-transcriptomic-signature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology